This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 4 and 11
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is a multi-center, randomized, double-blinded, placebo-controlled, parallel, 4-week study in 60 pediatric patients (4-11 years old) with asthma, comparing E004 with Placebo HFA-MDI in pediatric patients who are 4-11 years of age with asthma.

Provided treatments

  • Drug: E004 (Epinephrine Inhalation Aerosol) HFA-MDI
  • Drug: Placebo-HFA

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01460511. The sponsor of the trial is Amphastar Pharmaceuticals, Inc. and it is looking for 70 volunteers for the current phase.
Official trial title:
Phase III Study of Epinephrine Inhalation Aerosol for Evaluation of Efficacy and Safety of E004 in Children With Asthma